Developer docs
API playgroundTry for free, no card

Search company profiles

EO Care

Full company profile

uuid000d7rv

Namestring
EO Care
Legal namestring
EO Care, Inc.
Websiteurl
eo.care
Company typeenum
Private
Founded yearint
2022
Descriptiontext

EO Care, Inc. is a Boston, Massachusetts-based digital health company founded in 2022 that delivers personalized, clinically guided cannabinoid-based symptom management to older adults, adults in cancer treatment, and cancer survivors. The company's core platform is a free care plan (accessible at app.eo.care) that ingests patient symptoms, relevant medical history, concurrent medications, daily schedule, and ongoing feedback, then generates product, dose, and timing recommendations. These recommendations are produced by a proprietary rules-based Bayesian guidance engine — informed by 10,000+ prior cannabis-care patient interactions and a proprietary cannabinoid ontology — and translated into patient-facing language by a large language model on a HIPAA- and SOC-2-compliant infrastructure with human clinician review triggered for specified clinical criteria. Alongside the platform, EO Care sells a clinician-designed line of federally legal, hemp-derived precision-dosed products (Rapid Relief THC Inhaler, Guided Relief+ Gummies, Guided Bedtime Gummies, Guided Rest CBD & CBN Capsules, Guided Spot Relief Topical, and Sleep/Pain/Gummy bundles) through its DTC e-commerce store at shop.eo.care, with up to 20% off for care plan members, shipping to all US states except Idaho.

The company monetizes through three revenue streams: one-time DTC product sales, a freemium care plan whose discount mechanic drives repeat purchase, and subscription/enterprise contracts selling cannabis care benefits to employers and health plans (serving employees and members dealing with cancer, chronic pain, opioid replacement, anxiety, and sleep management). Its go-to-market combines educational content marketing, SEO, organic social, PR coverage (Boston Globe, CBSN, Fox, NBC Boston), webinars, and an advocacy-driven referral network built on partnerships with cancer support organizations (Imerman Angels, Twist Out Cancer, Cancer Support Community, Unite for Her, Stupid Cancer) and retiree associations (Mass Retirees), supplemented by clinician recommendation channels at Mayo Clinic, Mount Sinai, Northwell Health, Penn Medicine, UVA Health, and Jefferson Health.

EO Care is led by Co-Founder and CEO Sean Collins, with a clinical team including Chief Medical Officer Dr. Brooke Worster (Director of Supportive Oncology at Jefferson Health), Chief Cannabis Clinician Dr. Ben Caplan (18,000+ cannabis patients overseen), and Geriatric Clinical Pharmacist Dr. Emily Hajjar. Governance is reinforced by a board that includes Bill Van Faasen (former CEO of Blue Cross Blue Shield of Massachusetts), Kristi Savacool (former CEO of Aon Hewitt), and William Fleming (former Humana executive), alongside a Clinical Advisory Board that includes former US Surgeon General Dr. Regina Benjamin — a configuration oriented toward payer and employer adoption rather than pure consumer growth.

Short descriptiontext

EO Care is a Boston-based digital health company, founded in 2022, that pairs a free, AI-assisted Bayesian care plan with direct-to-consumer sales of precision-dosed cannabinoid products, serving older adults and cancer patients and survivors seeking clinically guided symptom management.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWellesley Hills, United States
HQ citystring
Wellesley Hills
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabinoid care platform, digital symptom management, personalized cannabis guidance, clinical decision support, cannabinoid product sales
Industry4 codes
1Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services)
CodeCRANAFAIPrimaryYes
2Patient Intake, Digital Registration & eForms
CodeHLACAEAFPrimaryNo
3Health & Pharmacy Omnichannel
CodeCRAFAEAKPrimaryNo
4eCOA/ePRO/eDiary & Patient-Facing Data Collection
CodeHLACAOABPrimaryNo
NAICS code2 codes
  • Pharmacies and Drug Retailers456110
  • Offices of Physicians6211
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Cannabinoid Care Platform
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Product Sales
TypeOne Time License
Description

EO Care generates revenue through the sale of cannabinoid-based products including inhalers, gummies, tablets, tinctures, topicals, and beverage shots. Products are sold directly through the company's e-commerce store (shop.eo.care) with prices varying by product type. Care plan members receive up to 20% discount on all products in their plan.

eo.care
2Care Plan Membership (Discount Program)
TypeFreemium
Description

Free care plans that provide personalized guidance and ongoing product/dose/use recommendations. While the care plan itself is free, members benefit from discounts on products (up to 20% off), creating a membership-like value proposition that encourages continued engagement and purchases.

eo.care
3B2B Enterprise Sales (Employers & Health Plans)
TypeSubscription Recurring
Description

EO Care offers cannabis care benefits to employers and health plans, providing clinical guidance services for employees and members dealing with cancer, chronic pain, opioid replacement, anxiety, and sleep management. This B2B channel provides another revenue stream through enterprise contracts.

eo.care
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations, Infrastructure
Pricing details1 tier
1Free Care Plan with Product Discounts
ModelFreemiumBilling cadencePay-as-you-go
Notes

Care plan is free; products ordered through plan receive up to 20% discount. Products available for purchase include inhalers, gummies, tablets, tinctures, topicals, and beverage shots at various price points.

eo.care
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

EO Care is a digital health platform that sells clinician-designed, federally legal hemp-derived cannabinoid products (THC inhalers, gummies, capsules, topicals, and bundles) direct-to-consumer via shop.eo.care, paired with a free personalized care plan platform (app.eo.care) that delivers ongoing AI-guided product, dose, and use recommendations for older adults, cancer patients, and cancer survivors. The company also offers B2B cannabis care benefits to employers and health plans, supported by HIPAA-compliant infrastructure, FDA-registered GMP-certified manufacturing, and clinician-led phone support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Significant improvements in pain, sleep, anxiety, and nausea/vomiting sustained over four weeks, particularly among older adults and cancer patients
+3 more records
Product overview1 text field

EO Care is a digital health platform offering a comprehensive portfolio of purpose-designed, precision-dosed cannabinoid products integrated with a free personalized care guidance platform. The product lineup includes THC inhalers, gummies (Relief+, Bedtime), CBD/CBN capsules, and precision topicals, available individually or bundled (Sleep Bundle, Pain Bundle, Gummy Bundle). All products are clinician-designed, shipped direct-to-door with free clinician support, and are federally legal hemp-derived formulations containing less than 0.3% THC. The platform leverages Bayesian guidance models and LLM AI to generate and continuously refine personalized care plans.

Product and service6 records
1Rapid Relief THC Inhaler
CategoryCannabinoid Inhalable Product
Description

Metered-dose THC inhaler using the same propellants and design as standard medical inhalers, purpose-designed by clinicians to provide rapid relief from aches, pains, and stress. Uses hemp-derived Delta-9 THC to increase availability and minimize intoxicating effects. Sold direct-to-consumer through shop.eo.care.

2Guided Relief+ Gummies
CategoryCannabinoid Edible Product
Description

Clinician-created cannabinoid and terpene formulation gummies designed to help manage daily aches, pains, and stress. Split neatly for optimal dosing in an easy-to-use magnetic seal box. Sold direct-to-consumer through shop.eo.care.

3Guided Bedtime Gummies
CategoryCannabinoid Edible Product
Description

Clinician-created cannabinoid and terpene formulation gummies designed to relax the mind and body and enable deep, restful sleep. Split neatly for optimal dosing in an easy-to-use magnetic seal box. Sold direct-to-consumer through shop.eo.care.

4Guided Rest CBD & CBN Capsules
CategoryCannabinoid Capsule Product
Description

Capsules combining CBD and CBN designed to help relax the mind and body so users can fall asleep faster and get deep, restful sleep. Sold direct-to-consumer through shop.eo.care.

5Guided Spot Relief Precision-Dosed Topical
CategoryCannabinoid Topical Product
Description

Precision-dosed topical designed to soothe aching joints and muscles. Non-intoxicating and daytime-friendly. Sold direct-to-consumer through shop.eo.care.

6Free Personalized Care Plan Platform
CategoryDigital Health Platform
Description

Digital health platform providing clinically responsible, ongoing product, dose, and use guidance based on symptoms, medical record, medications, daily schedule, and regular patient feedback. Includes up to 20% off all products in the plan. Features HIPAA-compliant messaging with the clinical team, check-in surveys, and iterative plan refinement powered by a Bayesian guidance engine and LLM AI translation layer. Accessible to older adults, cancer patients, and cancer survivors at no cost.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-10
Description

Mass Retirees collaborated with EO Care to provide medical cannabis resources to its members following a survey showing 70% of members interested in medical cannabis. The partnership addresses the lack of reliable information and guidance on cannabis use for medical purposes, with EO Care providing clinically responsible cannabinoid care access.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-11-02
Description

Non-profit cancer survivor and caregiver support community partnered with EO Care to provide cannabis care and advice to tens of thousands of members. The partnership provides educational content including whether cannabis is right for them, how to optimize use, and even how to reduce use.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Imerman Angels partnered with EO Care to provide clinically guided cannabis care and advice to members. The partnership addresses the finding that 40% of cancer patients use cannabis but many lack clinical guidance.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cancer Support Community partnered with EO Care to provide cancer patients, survivors, and caregivers with comprehensive clinically guided cannabis support.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Premium cannabis wellness brand positioned around dosage, design, and clinical credibility. Closely comparable to EO Care's positioning on precision-dosed, clinician-designed products aimed at older and health-conscious consumers.

TypeDirect peer
Description

California-based cannabis delivery marketplace with a wellness vertical. Comparable as a DTC cannabis commerce and care platform, though Eaze is a marketplace model rather than vertically integrated like EO Care's product-plus-care approach.

TypeDirect peer
Description

Vertically integrated California cannabis operator with branded products and retail. Overlaps with EO Care on the proprietary clinician-designed product portfolio and DTC distribution model, though Caliva is dispensary-led rather than digital-health-led.

TypeDirect peer
Description

Largest US cannabis telemedicine platform, providing physician evaluations and cannabis recommendations. Comparable to EO Care on the digital clinical-evaluation layer, though NuggMD focuses on cert/recommendation rather than ongoing care plans and product fulfillment.

TypeDirect peer
Description

Premium cannabis edibles brand with emphasis on consistent dosing and GMP manufacturing. Comparable to EO Care's guided gummy and capsule SKUs in terms of precision dosing, brand positioning, and target consumer profile.

6Ro
TypeBroad incumbent
Description

Direct-to-patient telehealth platform operating vertically integrated care across multiple conditions. Compares to EO Care's clinician-led care-plan engine and B2B employer motion, though Ro serves broader therapeutic areas.

TypeDirect peer
Description

Cannabis-focused telemedicine service providing medical marijuana evaluations. Direct overlap on digital cannabis clinical services, with comparable patient acquisition through online assessments and clinician recommendations.

TypeDirect peer
Description

Cannabis telehealth platform connecting patients with clinicians for medical cannabis recommendations. Directly comparable to EO Care's clinical-care-plan model, though Leafwell is broader in patient population while EO Care focuses on older adults and cancer patients.

TypeDirect peer
Description

Cannabis telehealth and education platform offering medical marijuana card evaluations and clinician consultations. Overlaps with EO Care's patient-facing clinical cannabis guidance, though Veriheal leans on third-party dispensaries rather than proprietary products.

TypeBroad incumbent
Description

Large direct-to-consumer telehealth and wellness platform. Analogous GTM model (DTC + provider-led care plans + subscription) and clinical digital infrastructure, though operating in mainstream categories rather than cannabis specifically.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EO Care

Cannabinoid Care Platformeo.care

EO Care is a Boston-based digital health company, founded in 2022, that pairs a free, AI-assisted Bayesian care plan with direct-to-consumer sales of precision-dosed cannabinoid products, serving older adults and cancer patients and survivors seeking clinically guided symptom management.

What EO Care does

EO Care, Inc. is a Boston, Massachusetts-based digital health company founded in 2022 that delivers personalized, clinically guided cannabinoid-based symptom management to older adults, adults in cancer treatment, and cancer survivors. The company's core platform is a free care plan (accessible at app.eo.care) that ingests patient symptoms, relevant medical history, concurrent medications, daily schedule, and ongoing feedback, then generates product, dose, and timing recommendations. These recommendations are produced by a proprietary rules-based Bayesian guidance engine — informed by 10,000+ prior cannabis-care patient interactions and a proprietary cannabinoid ontology — and translated into patient-facing language by a large language model on a HIPAA- and SOC-2-compliant infrastructure with human clinician review triggered for specified clinical criteria. Alongside the platform, EO Care sells a clinician-designed line of federally legal, hemp-derived precision-dosed products (Rapid Relief THC Inhaler, Guided Relief+ Gummies, Guided Bedtime Gummies, Guided Rest CBD & CBN Capsules, Guided Spot Relief Topical, and Sleep/Pain/Gummy bundles) through its DTC e-commerce store at shop.eo.care, with up to 20% off for care plan members, shipping to all US states except Idaho.

The company monetizes through three revenue streams: one-time DTC product sales, a freemium care plan whose discount mechanic drives repeat purchase, and subscription/enterprise contracts selling cannabis care benefits to employers and health plans (serving employees and members dealing with cancer, chronic pain, opioid replacement, anxiety, and sleep management). Its go-to-market combines educational content marketing, SEO, organic social, PR coverage (Boston Globe, CBSN, Fox, NBC Boston), webinars, and an advocacy-driven referral network built on partnerships with cancer support organizations (Imerman Angels, Twist Out Cancer, Cancer Support Community, Unite for Her, Stupid Cancer) and retiree associations (Mass Retirees), supplemented by clinician recommendation channels at Mayo Clinic, Mount Sinai, Northwell Health, Penn Medicine, UVA Health, and Jefferson Health.

EO Care is led by Co-Founder and CEO Sean Collins, with a clinical team including Chief Medical Officer Dr. Brooke Worster (Director of Supportive Oncology at Jefferson Health), Chief Cannabis Clinician Dr. Ben Caplan (18,000+ cannabis patients overseen), and Geriatric Clinical Pharmacist Dr. Emily Hajjar. Governance is reinforced by a board that includes Bill Van Faasen (former CEO of Blue Cross Blue Shield of Massachusetts), Kristi Savacool (former CEO of Aon Hewitt), and William Fleming (former Humana executive), alongside a Clinical Advisory Board that includes former US Surgeon General Dr. Regina Benjamin — a configuration oriented toward payer and employer adoption rather than pure consumer growth.

EO Care firmographics

Firmographics
Name
EO Care
Legal name
EO Care, Inc.
Website
https://eo.care
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
EO Care is a Boston-based digital health company, founded in 2022, that pairs a free, AI-assisted Bayesian care plan with direct-to-consumer sales of precision-dosed cannabinoid products, serving older adults and cancer patients and survivors seeking clinically guided symptom management.
Ownership category
akta.pro rank

EO Care industry classification

Industry
Product category
Cannabinoid Care Platform
NAICS
Pharmacies and Drug Retailers (456110), Offices of Physicians (6211)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
akta.pro secondary industries
Patient Intake, Digital Registration & eForms (HLACAEAF), Health & Pharmacy Omnichannel (CRAFAEAK), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

  • Cannabinoid care platform
  • Digital symptom management
  • Personalized cannabis guidance
  • Clinical decision support
  • Cannabinoid product sales

Where EO Care is headquartered

Location

Headquarters

HQ city
Wellesley Hills
HQ country
United States
HQ region
North America

Offices1 record

Markets served

EO Care business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations, Infrastructure

Revenue model

  1. Product Sales: EO Care generates revenue through the sale of cannabinoid-based products including inhalers, gummies, tablets, tinctures, topicals, and beverage shots. Products are sold directly through the company's e-commerce store (shop.eo.care) with prices varying by product type. Care plan members receive up to 20% discount on all products in their plan.
  2. Care Plan Membership (Discount Program): Free care plans that provide personalized guidance and ongoing product/dose/use recommendations. While the care plan itself is free, members benefit from discounts on products (up to 20% off), creating a membership-like value proposition that encourages continued engagement and purchases.
  3. B2B Enterprise Sales (Employers & Health Plans): EO Care offers cannabis care benefits to employers and health plans, providing clinical guidance services for employees and members dealing with cancer, chronic pain, opioid replacement, anxiety, and sleep management. This B2B channel provides another revenue stream through enterprise contracts.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree Care Plan with Product Discounts

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

EO Care product offering

Product offering

Core offering

EO Care is a digital health platform that sells clinician-designed, federally legal hemp-derived cannabinoid products (THC inhalers, gummies, capsules, topicals, and bundles) direct-to-consumer via shop.eo.care, paired with a free personalized care plan platform (app.eo.care) that delivers ongoing AI-guided product, dose, and use recommendations for older adults, cancer patients, and cancer survivors. The company also offers B2B cannabis care benefits to employers and health plans, supported by HIPAA-compliant infrastructure, FDA-registered GMP-certified manufacturing, and clinician-led phone support.

Product overview

EO Care is a digital health platform offering a comprehensive portfolio of purpose-designed, precision-dosed cannabinoid products integrated with a free personalized care guidance platform. The product lineup includes THC inhalers, gummies (Relief+, Bedtime), CBD/CBN capsules, and precision topicals, available individually or bundled (Sleep Bundle, Pain Bundle, Gummy Bundle). All products are clinician-designed, shipped direct-to-door with free clinician support, and are federally legal hemp-derived formulations containing less than 0.3% THC. The platform leverages Bayesian guidance models and LLM AI to generate and continuously refine personalized care plans.

Differentiator

Problem solved

Functional benefit

Products and services

  • Rapid Relief THC Inhaler Metered-dose THC inhaler using the same propellants and design as standard medical inhalers, purpose-designed by clinicians to provide rapid relief from aches, pains, and stress. Uses hemp-derived Delta-9 THC to increase availability and minimize intoxicating effects. Sold direct-to-consumer through shop.eo.care.
  • Guided Relief+ Gummies Clinician-created cannabinoid and terpene formulation gummies designed to help manage daily aches, pains, and stress. Split neatly for optimal dosing in an easy-to-use magnetic seal box. Sold direct-to-consumer through shop.eo.care.
  • Guided Bedtime Gummies Clinician-created cannabinoid and terpene formulation gummies designed to relax the mind and body and enable deep, restful sleep. Split neatly for optimal dosing in an easy-to-use magnetic seal box. Sold direct-to-consumer through shop.eo.care.
  • Guided Rest CBD & CBN Capsules Capsules combining CBD and CBN designed to help relax the mind and body so users can fall asleep faster and get deep, restful sleep. Sold direct-to-consumer through shop.eo.care.
  • Guided Spot Relief Precision-Dosed Topical Precision-dosed topical designed to soothe aching joints and muscles. Non-intoxicating and daytime-friendly. Sold direct-to-consumer through shop.eo.care.
  • Free Personalized Care Plan Platform Digital health platform providing clinically responsible, ongoing product, dose, and use guidance based on symptoms, medical record, medications, daily schedule, and regular patient feedback. Includes up to 20% off all products in the plan. Features HIPAA-compliant messaging with the clinical team, check-in surveys, and iterative plan refinement powered by a Bayesian guidance engine and LLM AI translation layer. Accessible to older adults, cancer patients, and cancer survivors at no cost.

Quantifiable outcome

  • Significant improvements in pain, sleep, anxiety, and nausea/vomiting sustained over four weeks, particularly among older adults and cancer patients
  • +3 more outcomes

Companies that use EO Care

Customer profile

Named customers13 records

Segments3 records

Ideal customer profiles3 records

EO Care technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

EO Care partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core.

  • Mass RetireescoreStrategic or Co-development Partner · 10 July 2024Mass Retirees collaborated with EO Care to provide medical cannabis resources to its members following a survey showing 70% of members interested in medical cannabis. The partnership addresses the lack of reliable information and guidance on cannabis use for medical purposes, with EO Care providing clinically responsible cannabinoid care access.
  • Twist Out CancercoreStrategic or Co-development Partner · 2 November 2023Non-profit cancer survivor and caregiver support community partnered with EO Care to provide cannabis care and advice to tens of thousands of members. The partnership provides educational content including whether cannabis is right for them, how to optimize use, and even how to reduce use.
  • Imerman AngelscoreStrategic or Co-development PartnerImerman Angels partnered with EO Care to provide clinically guided cannabis care and advice to members. The partnership addresses the finding that 40% of cancer patients use cannabis but many lack clinical guidance.
  • Cancer Support CommunitycoreStrategic or Co-development PartnerCancer Support Community partnered with EO Care to provide cancer patients, survivors, and caregivers with comprehensive clinically guided cannabis support.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

EO Care competitors and assessment

Company assessment

Direct peers

  • Beboe: Premium cannabis wellness brand positioned around dosage, design, and clinical credibility. Closely comparable to EO Care's positioning on precision-dosed, clinician-designed products aimed at older and health-conscious consumers.
  • Eaze: California-based cannabis delivery marketplace with a wellness vertical. Comparable as a DTC cannabis commerce and care platform, though Eaze is a marketplace model rather than vertically integrated like EO Care's product-plus-care approach.
  • Caliva: Vertically integrated California cannabis operator with branded products and retail. Overlaps with EO Care on the proprietary clinician-designed product portfolio and DTC distribution model, though Caliva is dispensary-led rather than digital-health-led.
  • NuggMD: Largest US cannabis telemedicine platform, providing physician evaluations and cannabis recommendations. Comparable to EO Care on the digital clinical-evaluation layer, though NuggMD focuses on cert/recommendation rather than ongoing care plans and product fulfillment.
  • Kiva Confections: Premium cannabis edibles brand with emphasis on consistent dosing and GMP manufacturing. Comparable to EO Care's guided gummy and capsule SKUs in terms of precision dosing, brand positioning, and target consumer profile.
  • PrestoDoctor: Cannabis-focused telemedicine service providing medical marijuana evaluations. Direct overlap on digital cannabis clinical services, with comparable patient acquisition through online assessments and clinician recommendations.
  • Leafwell: Cannabis telehealth platform connecting patients with clinicians for medical cannabis recommendations. Directly comparable to EO Care's clinical-care-plan model, though Leafwell is broader in patient population while EO Care focuses on older adults and cancer patients.
  • Veriheal: Cannabis telehealth and education platform offering medical marijuana card evaluations and clinician consultations. Overlaps with EO Care's patient-facing clinical cannabis guidance, though Veriheal leans on third-party dispensaries rather than proprietary products.

Broad incumbents

  • Ro: Direct-to-patient telehealth platform operating vertically integrated care across multiple conditions. Compares to EO Care's clinician-led care-plan engine and B2B employer motion, though Ro serves broader therapeutic areas.
  • Hims & Hers Health: Large direct-to-consumer telehealth and wellness platform. Analogous GTM model (DTC + provider-led care plans + subscription) and clinical digital infrastructure, though operating in mainstream categories rather than cannabis specifically.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

EO Care social profiles

Digital presence

EO Care compliance and trust

Trust signal

Compliance4 records

EO Care financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EO Care leadership team

Management profile

Number of profiles

Profiles8 records

EO Care funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EO Care M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EO Care

What does EO Care do?

EO Care is a digital health platform that sells clinician-designed, federally legal hemp-derived cannabinoid products (THC inhalers, gummies, capsules, topicals, and bundles) direct-to-consumer via shop.eo.care, paired with a free personalized care plan platform (app.eo.care) that delivers ongoing AI-guided product, dose, and use recommendations for older adults, cancer patients, and cancer survivors. The company also offers B2B cannabis care benefits to employers and health plans, supported by HIPAA-compliant infrastructure, FDA-registered GMP-certified manufacturing, and clinician-led phone support.

Is EO Care a public or private company?

EO Care is a private company. It is classified as venture growth investor backed and is currently operating.

When was EO Care founded?

EO Care was founded in 2022. It employs 11 to 50 people.

Where is EO Care based?

EO Care is headquartered in Wellesley Hills, United States, in the North America region.

How does EO Care make money?

Three revenue lines are on record. Product Sales are the primary driver. The others are care Plan Membership (Discount Program) and B2B Enterprise Sales (Employers & Health Plans).

Who are EO Care's main competitors?

Direct peers on record are Beboe, Eaze, Caliva, NuggMD, Kiva Confections, PrestoDoctor, Leafwell and Veriheal. Broad incumbents are Ro and Hims & Hers Health.

Does EO Care have an API?

No public API is recorded for EO Care.

What industry is EO Care in?

EO Care's product category is Cannabinoid Care Platform. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of HLACAEAF, Patient Intake, Digital Registration & eForms. Its NAICS code is 456110 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogEO Care Joins the Personify Health Partner Marketplace, Expanding Employer Access to Clinically Guided Cancer Symptom Management SolutionEO Care joined the Personify Health Partner Marketplace to offer employer access to its cannabinoid-based cancer symptom management. The program reports 79% of patients achieve clinically meaningful anxiety improvement and 56% pain improvement, with over 92% onboarding unassisted.OncLiveModel Validates Cost Savings With Cannabis in Mitigating Symptoms for Patients With CancerEO Care created a health care cost impacts model for cannabis-based treatments to mitigate cancer treatment symptoms, reviewed by Milliman. Milliman deemed the model reasonable, suggesting cost savings and recommending an observational study once cannabis rescheduling data is available.Business Wire BlogEO Care Releases Latest Cannabinoid-Based Symptom Management Efficacy Data for Pain, Sleep, Anxiety, and Nausea/VomitingEO Care, Inc. released clinical data demonstrating that patients using its guided cannabinoid-based symptom management platform reported meaningful improvements in pain, sleep, anxiety, and nausea/vomiting, with improvement rates ranging from 55% to 81% among patients over 50 after one to four weeks of use. Cancer patients showed particularly strong outcomes, with 92% reporting meaningful improvement in nausea/vomiting and 77% experiencing meaningful improvements in both sleep disturbance and anxiety after four weeks. The company cited a lack of existing data on cannabinoid care effectiveness and positioned this real-world evidence as a foundation for scalable, clinically responsible symptom management solutions targeting older adults and cancer patients.MassretireesEO Care Study: Promising Results – Mass RetireesEO Care, a Massachusetts-based company, is conducting studies on the impact of medical cannabis on healthcare costs, finding potential reductions of 3% to 5% in overall expenses for patients experiencing pain, anxiety, and other medical conditions. The company is collaborating with Mass Retirees to provide discounted services and reliable information on medical cannabis to its members, highlighting a significant interest in cannabis as a treatment option. This collaboration addresses the need for guidance in safely using medical cannabis, especially among older populations.GlobeNewswireCancer Support Community Imerman Angels Partners with EO Care to Offer Clinically Guided Cannabis Care and Advice to MembersImerman Angels, a cancer support community, partnered with EO Care to provide clinically guided cannabis care content. The partnership aims to give cancer patients access to evidence-based guidance on cannabis use, addressing the lack of clinical advice. EO Care's service is built on data from over 18,000 clinician-patient interactions.GreenStateMajority of Americans would try medical cannabis with one caveatA survey conducted by EO Care, a Boston-based cannabis health and wellness company, found that 65% of American adults would be likely to use medical marijuana if it were screened and dosed by a doctor, while 51% would be likely to use it if their employers covered it as a benefit. The survey of 1,027 respondents in states where cannabis is legal found that 19% had consumed cannabis for health reasons in the past year, primarily for anxiety, pain, and sleep issues. The findings highlight a gap between the healthcare and cannabis industries, with most consumers relying on dispensary staff rather than medical professionals for guidance on medical cannabis.GlobeNewswireNon-Profit Twist Out Cancer Partners with EO Care to Provide Clinically Guided Cannabis Care and Advice to MembersNon-profit organization Twist Out Cancer, which provides psychosocial support to cancer previvors, survivors, and caregivers through creative arts programming, has partnered with EO Care to become its cannabis care content partner. EO Care is a digital health company offering clinically guided cannabis wellness solutions for employers, payers, and associations, and will provide educational materials to Twist Out Cancer's community on whether cannabis is appropriate for individual patients, how to optimize use, and how to reduce use. The partnership addresses a documented gap in clinical guidance for cancer patients, as medical cannabis—legal in 39 states and used by up to an estimated 40% of cancer patients—is typically not prescribed by physicians, leaving patients to navigate dispensary staff who are not trained clinicians.YahooEO Launches First-Ever Digital Health Platform Offering Affordable, Clinician-Guided Cannabis CareEO Care, Inc., a Boston-based digital health company focused on cannabinoid-based treatments, announced the launch of a HIPAA-compliant service and technology platform offering affordable, clinically overseen cannabis care for patients suffering from chronic pain, sleeplessness and anxiety. The platform combines a patient companion app with a proprietary data model, enabling personalized care plans, real-time clinician messaging, telehealth consultations, and cannabis product delivery through retail partners. Board members include Bill Van Faasen, former Chairman and CEO of Blue Cross/Blue Shield of Massachusetts, and Steve Hoffman, former Chairman of the Massachusetts Cannabis Control Commission.